Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CLSK vs CD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CLSK Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 6–4 Matrix Metrics)

CLSK Overall Winner 6-Pillar Tally: CLSK 3 – 2 CD (1 Tie) Matrix Metrics: CLSK 6 – 4 CD

As of Nov 16, 2026, Cleanspark Inc (CLSK) is the stronger overall head-to-head candidate over CD (CD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CLSK carries a Unified Composite Score of 50.7/100 (HOLD) at $6.27 (30.5x Forward P/E, -189.5% operating margin), whereas CD carries 46.1/100 (HOLD) at $3.52 (N/M Forward P/E, -187.2% operating margin).

  • Growth vs. Quality Trade-Off: CLSK earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. CD 46.1/100 HOLD) and 3.28β · 127% Vol risk profile, whereas CD leads top-line expansion (+98.4% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile CD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 34.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CLSK vs CD
CLSK NASDAQ Head-to-Head Winner
Cleanspark Inc
Finance Services
$6.27
-5.72% 1D
Market Cap $1.7B
TTM Revenue $679M
Forward P/E 30.5x
Beta / 30D Vol 3.28β · 127% Vol
Unified Composite Score
50.7 / 100 HOLD
Tech 45.0 Fund 57.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.1%), weak momentum, RSI 35
RSI-14: 35.4 · SMA20: $7.39 · SMA50: $10.36
CD US Equity
CD
Institutional Equity
$3.52
-17.49% 1D
Market Cap $576.4M
TTM Revenue $2.6M
Forward P/E N/M
Beta / 30D Vol 2.59β · 186% Vol
Unified Composite Score
46.1 / 100 HOLD
Tech 33.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 34
RSI-14: 34.2 · SMA20: $6.72 · SMA50: $6.09

6-Pillar Scorecard Institutional Category Breakdown (CLSK 3 – 2 CD)

Columns: Metric · CLSK · CD
1. Valuation Multiples CLSK
Forward P/E 30.5x N/M
Trailing P/E 30.5x N/M
PEG Ratio N/M N/M
EV / Revenue 4.8x N/M
2. Growth & Scale CLSK
Revenue Growth (YoY) -30.5% +98.4%
Earnings Growth (YoY) +491.6% +0.0%
TTM Revenue (USD) $679M $2.6M
Market Cap $1.7B $576.4M
3. Profitability & Quality CD
Gross Margin 47.0% 59.8%
Operating Margin -189.5% -187.2%
Net Profit Margin -146.9% -182.5%
Return on Equity (ROE) -68.6% -7.7%
4. Balance Sheet & Cash Flow CD
Cash Generation (TTM) -$1.04B -$4.5M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $1.58B Net Debt (2.35x D/E) $0.59 Book/Sh · -7.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CLSK
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 100.6% (47th %ile) 126.6% (<1st %ile)
Put/Call OI Skew 0.66x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CLSK (6) vs CD (4)
Institutional Metric CLSK CD Criterion Row Edge
Market Capitalization
Scale
$1.7B $576.4M Larger Scale CLSK
Trailing P/E Ratio
Valuation
30.5x N/M Lower Multiple CLSK
Forward P/E Ratio
Valuation
30.5x N/M Lower Multiple CLSK
Revenue Growth (YoY)
Growth
-30.5% +98.4% Higher Growth CD
Operating Margin (TTM)
Profitability
-189.5% -187.2% Higher Margin CD
Net Profit Margin
Profitability
-146.9% -182.5% Higher Margin CLSK
Return on Equity (ROE)
Capital Efficiency
-68.6% -7.7% Higher ROE CD
52-Week Range Position
Momentum
5% ($6–$19) 12% ($2–$14) Stronger Trend CD
Beta / 30D Volatility
Risk Regime
3.28β · 127% Vol 2.59β · 186% Vol Lower Realized Risk CLSK
Unified Institutional Score
Composite Signal
50.7 / 100 (HOLD) 46.1 / 100 (HOLD) Higher Composite CLSK
Trailing 12M Revenue (USD)
Operating Scale
$679M $2.6M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.0% 59.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.8x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$1.04B ($1.58B Net Debt (2.35x D/E)) -$4.5M EBITDA ($0.59 Book/Sh · -7.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CLSK +23.92 pp
CLSK: -25.36% · CD: -49.28%
3M Horizon CD +42.85 pp
CLSK: -46.55% · CD: -3.7%
6M Horizon CLSK +13.14 pp
CLSK: -53.35% · CD: -66.49%
1Y Horizon CLSK +11.42 pp
CLSK: -47.66% · CD: -59.08%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLSK vs CD. Trailing 12-month operating profitability (CLSK -189.5% vs CD -187.2%) and valuation multiples (CLSK 30.5x vs CD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CLSK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$679M
Gross Margin47.0%
Op. Margin-189.5%
ROE / Fwd P/E-68.6% · 30.5x
CD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.6M
Gross Margin59.8%
Op. Margin-187.2%
ROE / Fwd P/E-7.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CLSK BREAKDOWN
117d in phase · OBV NEUTRAL
Current IV 100.6%
IV Percentile 47th %ile
Put/Call OI Skew 0.66x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CLSK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 126.6%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CLSK Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $1.7B market capitalization and -189.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CD Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $576.4M market capitalization and -187.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CLSK vs CD Key Questions & Quantitative Answers

As of Nov 16, 2026, Cleanspark Inc (CLSK) is the stronger overall head-to-head candidate over CD (CD) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CLSK carries a Unified Composite Score of 50.7/100 (HOLD) at $6.27 (30.5x Forward P/E, -189.5% operating margin), whereas CD carries 46.1/100 (HOLD) at $3.52 (N/M Forward P/E, -187.2% operating margin). Growth vs. Quality Trade-Off: CLSK earns the overall head-to-head edge with a stronger Unified Composite Score (50.7/100 HOLD vs. CD 46.1/100 HOLD) and 3.28β · 127% Vol risk profile, whereas CD leads top-line expansion (+98.4% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile CD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 34.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CLSK leads the Growth & Scale pillar: CLSK posts -30.5% YoY revenue growth and +491.6% YoY earnings growth on $679M TTM revenue (47.0% gross margin, -189.5% operating margin), compared with CD at +98.4% YoY revenue growth and +0.0% YoY earnings growth on $2.6M TTM revenue (59.8% gross margin, -187.2% operating margin). On trailing 12-month operating scale, CLSK generates $679M in USD-normalized revenue versus $2.6M for CD. In operating R&D and SG&A reinvestment, CLSK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CD.

CLSK screens cheaper on headline valuation multiples. CLSK trades at 30.5x Forward P/E, 30.5x Trailing P/E, N/M PEG, and 4.8x EV/Revenue (unreported FCF margin), whereas CD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CLSK (-68.6% ROE) versus CD (-7.7% ROE) capital efficiency.

In options market volatility and institutional positioning, CLSK carries 100.6% implied volatility (47th %ile, Balanced (25th–60th %ile)), a 0.66x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.28β · 127% Vol realized risk). By comparison, CD carries 126.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.59β · 186% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.